ALKS

Alkermes

1ALKS
IRL
NASDAQ

$23.81

24H

0.9%

Market Cap

4 B

Volume

1.1 M

Supply

167.1 M

Price Chart

About Alkermes - ALKS

Alkermes plc is a biopharmaceutical company that focuses on developing innovative medicines designed to address unmet medical needs in the fields of central nervous system (CNS) disorders, such as schizophrenia, depression, and addiction. The company's portfolio includes both marketed products and compounds in various stages of clinical development.

What are Alkermes's core values and mission statement?

Alkermes plc is focused on developing innovative medicines to improve patient outcomes in neuroscience and oncology. Their mission emphasizes their commitment to addressing unmet medical needs and advancing science in a way that contributes to society.

Who founded Alkermes and when?

Alkermes plc was founded by Michael Wall in 1987.

Who leads Alkermes?

As of my last update, Richard Pops serves as the Chairman and Chief Executive Officer of Alkermes plc.

Where is Alkermes located, and what is its base country?

Alkermes plc is headquartered in Dublin, Ireland, which is its base country.

On which exchanges is Alkermes traded?

Alkermes plc is traded on the NASDAQ under the ticker symbol ALKS.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

Alkermes (ALKS) Price Live Data

The live price of Alkermes (ALKS) is $23.81, with a trading volume of 1,129,752 in the last 24 hours. Wrapstocks updates the ALKS price in real-time. Alkermes is down -0.9% in the last 24 hours. The company has a live market cap of $3,977,244,160.00 and a supply of 167,075,999 ALKS stocks.

Alkermes (ALKS) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 14 hours and 19 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
14 hours and 19 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
16 Apr 2024 07:56 PM